|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI
|
|
2
|
Marx A, Chan JK, Coindre JM, Detterbeck F,
Girard N, Harris NL, Jaffe ES, Kurrer MO, Marom EM, Moreira AL, et
al: The 2015 World Health Organization classification of tumors of
the thymus: Continuity and changes. J Thorac Oncol. 10:1383–1395.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Adams SJ, Stone E, Baldwin DR,
Vliegenthart R, Lee P and Fintelmann FJ: Lung cancer screening.
Lancet. 401:390–408. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Asamura H, Nishimura KK, Giroux DJ,
Chansky K, Hoering A, Rusch V and Rami-Porta R; Members of the
IASLC Staging, Prognostic Factors Committee of the Advisory Boards,
Participating Institutions, : IASLC lung cancer staging project:
The new database to inform revisions in the ninth edition of the
TNM classification of lung cancer. J Thorac Oncol. 18:564–575.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thai AA, Solomon BJ, Sequist LV, Gainor JF
and Heist RS: Lung cancer. Lancet. 398:535–554. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ferrari M and Stagi S: Oxidative stress in
down and williams-beuren syndromes: An overview. Molecules.
26:31392021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zorbas C, Nicolas E, Wacheul L, Huvelle E,
Heurgué-Hamard V and Lafontaine DL: The human 18S rRNA base
methyltransferases DIMT1L and WBSCR22-TRMT112 but not rRNA
modification are required for ribosome biogenesis. Mol Biol Cell.
26:2080–2095. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Petrossian TC and Clarke SG: Uncovering
the human methyltransferasome. Mol Cell Proteomics. 10:M110.000976.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Õunap K, Käsper L, Kurg A and Kurg R: The
human WBSCR22 protein is involved in the biogenesis of the 40S
ribosomal subunits in mammalian cells. PLoS One. 8:e756862013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chi Y, Liang Z, Guo Y, Chen D, Lu L, Lin
J, Qiu S, Wang X, Qiu E, Lin F, et al: WBSCR22 confers cell
survival and predicts poor prognosis in glioma. Brain Res Bull.
161:1–12. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tiedemann RE, Zhu YX, Schmidt J, Shi CX,
Sereduk C, Yin H, Mousses S and Stewart AK: Identification of
molecular vulnerabilities in human multiple myeloma cells by RNA
interference lethality screening of the druggable genome. Cancer
Res. 72:757–768. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nakazawa Y, Arai H and Fujita N: The novel
metastasis promoter Merm1/Wbscr22 enhances tumor cell survival in
the vasculature by suppressing Zac1/p53-dependent apoptosis. Cancer
Res. 71:1146–1155. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Khan AA, Huang H, Zhao Y, Li H, Pan R,
Wang S and Liu X: WBSCR22 and TRMT112 synergistically suppress cell
proliferation, invasion and tumorigenesis in pancreatic cancer via
transcriptional regulation of ISG15. Int J Oncol. 60:242022.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yan D, Zheng X, Tu L, Jia J, Li Q, Cheng L
and Wang X: Knockdown of Merm1/Wbscr22 attenuates sensitivity of
H460 non-small cell lung cancer cells to SN-38 and 5-FU without
alteration to p53 expression levels. Mol Med Rep. 11:295–302. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gillette MA, Satpathy S, Cao S,
Dhanasekaran S, Vasaikar S, Krug K, Petralia F, Li Y, Liang WW,
Reva B, et al: A02 Proteogenomic characterization reveals
therapeutic vulnerabilities in lung adenocarcinoma. J Thorac Oncol.
15 (Suppl):S122020. View Article : Google Scholar
|
|
16
|
Satpathy S, Krug K, Jean Beltran PM,
Savage SR, Petralia F, Kumar-Sinha C, Dou Y, Reva B, Kane MH,
Avanessian SC, et al: A proteogenomic portrait of lung squamous
cell carcinoma. Cell. 184:4348–4371.e40. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rousseaux S, Debernardi A, Jacquiau B,
Vitte AL, Vesin A, Nagy-Mignotte H, Moro-Sibilot D, Brichon PY,
Lantuejoul S, Hainaut P, et al: Ectopic activation of germline and
placental genes identifies aggressive metastasis-prone lung
cancers. Sci Transl Med. 5:186ra662013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hou J, Aerts J, den Hamer B, van Ijcken W,
den Bakker M, Riegman P, van der Leest C, van der Spek P, Foekens
JA, Hoogsteden HC, et al: Gene expression-based classification of
non-small cell lung carcinomas and survival prediction. PLoS One.
5:e103122010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Y, Foreman O, Wigle DA, Kosari F,
Vasmatzis G, Salisbury JL, van Deursen J and Galardy PJ: USP44
regulates centrosome positioning to prevent aneuploidy and suppress
tumorigenesis. J Clin Invest. 122:4362–4374. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim IJ, Quigley D, To MD, Pham P, Lin K,
Jo B, Jen KY, Raz D, Kim J, Mao JH, et al: Rewiring of human lung
cell lineage and mitotic networks in lung adenocarcinomas. Nat
Commun. 4:17012013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Seo JS, Ju YS, Lee WC, Shin JY, Lee JK,
Bleazard T, Lee J, Jung YJ, Kim JO, Shin JY, et al: The
transcriptional landscape and mutational profile of lung
adenocarcinoma. Genome Res. 22:2109–2119. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Girard L, Rodriguez-Canales J, Behrens C,
Thompson DM, Botros IW, Tang H, Xie Y, Rekhtman N, Travis WD,
Wistuba II, et al: An expression signature as an aid to the
histologic classification of non-small cell lung cancer. Clin
Cancer Res. 22:4880–4889. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen CH, Lai JM, Chou TY, Chen CY, Su LJ,
Lee YC, Cheng TS, Hong YR, Chou CK, Whang-Peng J, et al: VEGFA
upregulates FLJ10540 and modulates migration and invasion of lung
cancer via PI3K/AKT pathway. PLoS One. 4:e50522009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wei TY, Juan CC, Hisa JY, Su LJ, Lee YC,
Chou HY, Chen JM, Wu YC, Chiu SC, Hsu CP, et al: Protein arginine
methyltransferase 5 is a potential oncoprotein that upregulates G1
cyclins/cyclin-dependent kinases and the phosphoinositide
3-kinase/AKT signaling cascade. Cancer Sci. 103:1640–1650. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Robles AI, Arai E, Mathé EA, Okayama H,
Schetter AJ, Brown D, Petersen D, Bowman ED, Noro R, Welsh JA, et
al: An integrated prognostic classifier for stage I lung
adenocarcinoma based on mRNA, microRNA, and DNA methylation
biomarkers. J Thorac Oncol. 10:1037–1048. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun Z, Wang L, Eckloff BW, Deng B, Wang Y,
Wampfler JA, Jang J, Wieben ED, Jen J, You M and Yang P: Conserved
recurrent gene mutations correlate with pathway deregulation and
clinical outcomes of lung adenocarcinoma in never-smokers. BMC Med
Genomics. 7:322014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li J, Wang B, Li X and Zhu Y: Estimation
of hub genes and infiltrating immune cells in non-smoking females
with lung adenocarcinoma by integrated bioinformatic analysis. Med
Sci Monitor. 26:e9226802020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Okayama H, Kohno T, Ishii Y, Shimada Y,
Shiraishi K, Iwakawa R, Furuta K, Tsuta K, Shibata T, Yamamoto S,
et al: Identification of genes upregulated in ALK-positive and
EGFR/KRAS/ALK-negative lung adenocarcinomas. Cancer Res.
72:100–111. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Győrffy B, Surowiak P, Budczies J and
Lánczky A: Online survival analysis software to assess the
prognostic value of biomarkers using transcriptomic data in
non-small-cell lung cancer. PLoS One. 8:e822412013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li T, Fan J, Wang B, Traugh N, Chen Q, Liu
JS, Li B and Liu XS: TIMER: A web server for comprehensive analysis
of tumor-infiltrating immune cells. Cancer Res. 77:e108–e110. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Racle J, de Jonge K, Baumgaertner P,
Speiser DE and Gfeller D: Simultaneous enumeration of cancer and
immune cell types from bulk tumor gene expression data. Elife.
6:e264762017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Becht E, Giraldo NA, Lacroix L, Buttard B,
Elarouci N, Petitprez F, Selves J, Laurent-Puig P, Sautès-Fridman
C, Fridman WH and de Reyniès A: Estimating the population abundance
of tissue-infiltrating immune and stromal cell populations using
gene expression. Genome Biol. 17:2182016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Finotello F, Mayer C, Plattner C,
Laschober G, Rieder D, Hackl H, Krogsdam A, Loncova Z, Posch W,
Wilflingseder D, et al: Molecular and pharmacological modulators of
the tumor immune contexture revealed by deconvolution of RNA-seq
data. Genome Med. 11:342019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yoshihara K, Shahmoradgoli M, Martínez E,
Vegesna R, Kim H, Torres-Garcia W, Treviño V, Shen H, Laird PW,
Levine DA, et al: Inferring tumour purity and stromal and immune
cell admixture from expression data. Nat Commun. 4:26122013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Charoentong P, Finotello F, Angelova M,
Mayer C, Efremova M, Rieder D, Hackl H and Trajanoski Z: Pan-cancer
immunogenomic analyses reveal genotype-immunophenotype
relationships and predictors of response to checkpoint blockade.
Cell Rep. 18:248–262. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chandrashekar DS, Karthikeyan SK, Korla
PK, Patel H, Shovon AR, Athar M, Netto GJ, Qin ZS, Kumar S, Manne
U, et al: UALCAN: An update to the integrated cancer data analysis
platform. Neoplasia. 25:18–27. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yuan H, Yan M, Zhang G, Liu W, Deng C,
Liao G, Xu L, Luo T, Yan H, Long Z, et al: CancerSEA: A cancer
single-cell state atlas. Nucl Acids Res. 47(D1): D900–D908. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Aliazis K, Christofides A, Shah R, Yeo YY,
Jiang S, Charest A and Boussiotis VA: The tumor microenvironment's
role in the response to immune checkpoint blockade. Nat Cancer.
6:924–937. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yan D, Tu L, Yuan H, Fang J, Cheng L,
Zheng X and Wang X: WBSCR22 confers oxaliplatin resistance in human
colorectal cancer. Sci Rep. 7:154432017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Stefanska B, Cheishvili D, Suderman M,
Arakelian A, Huang J, Hallett M, Han ZG, Al-Mahtab M, Akbar SM,
Khan WA, et al: Genome-wide study of hypomethylated and induced
genes in patients with liver cancer unravels novel anticancer
targets. Clin Cancer Res. 20:3118–3132. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Petitprez F, de Reyniès A, Keung EZ, Chen
TW, Sun CM, Calderaro J, Jeng YM, Hsiao LP, Lacroix L, Bougoüin A,
et al: B cells are associated with survival and immunotherapy
response in sarcoma. Nature. 577:556–560. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Helmink BA, Reddy SM, Gao J, Zhang S,
Basar R, Thakur R, Yizhak K, Sade-Feldman M, Blando J, Han G, et
al: B cells and tertiary lymphoid structures promote immunotherapy
response. Nature. 577:549–555. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Philip M, Fairchild L, Sun L, Viale A,
Merghoub T, Wolchok JD, Leslie CS and Schietinger A: Chromatin
state dynamics underlying CD8 T cell differentiation and
dysfunction in cancer. Blood. 128:8612016. View Article : Google Scholar
|
|
45
|
Stixová L, Tichý V and Bártová E:
RNA-related DNA damage and repair: The role of N7-methylguanosine
in the cell nucleus exposed to UV light. Heliyon. 10:e255992024.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zheng XL, Li ZD, Luo KZ, Li YL, Liu YH,
Shen SY, Shen FY, Li WY, Chen GQ, Zhang C and Zeng LH: POLR2J
expression promotes glioblastoma malignancy by regulating oxidative
stress and the STAT3 signaling pathway. Am J Cancer Res.
14:2037–2054. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Campbell JM, Lockwood WW, Buys TP, Chari
R, Coe BP, Lam S and Lam WL: Integrative genomic and gene
expression analysis of chromosome 7 identified novel oncogene loci
in non-small cell lung cancer. Genome. 51:1032–1039. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Nourbakhsh M, Saksager A, Tom N, Chen XS,
Colaprico A, Olsen C, Tiberti M and Papaleo E: A workflow to study
mechanistic indicators for driver gene prediction with moonlight.
Brief Bioinform. 24:bbad2742023. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yao L, Cong R, Ji C, Zhou X, Luan J, Meng
X and Song N: RNA-binding proteins play an important role in the
prognosis of patients with testicular germ cell tumor. Front Genet.
12:6102912021. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Costales-Carrera A, Fernández-Barral A,
Bustamante-Madrid P, Domínguez O, Guerra-Pastrián L, Cantero R, Del
Peso L, Burgos A, Barbáchano A and Muñoz A: Comparative study of
organoids from patient-derived normal and tumor colon and rectal
tissue. Cancers (Basel). 12:23022020. View Article : Google Scholar : PubMed/NCBI
|
